Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients.
Horwitz ME, Morris A, Gasparetto C, Sullivan K, Long G, Chute J, Rizzieri D, McPherson J, Chao N. Horwitz ME, et al. Among authors: chao n. Biol Blood Marrow Transplant. 2008 May;14(5):591-4. doi: 10.1016/j.bbmt.2008.02.016. Biol Blood Marrow Transplant. 2008. PMID: 18410902 Free PMC article. Clinical Trial.
Non-myeloablative umbilical cord blood transplantation.
Horwitz ME, Chao N. Horwitz ME, et al. Among authors: chao n. Best Pract Res Clin Haematol. 2010 Jun;23(2):231-6. doi: 10.1016/j.beha.2010.06.001. Best Pract Res Clin Haematol. 2010. PMID: 20837335 Review.
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
Green MM, Chao N, Chhabra S, Corbet K, Gasparetto C, Horwitz A, Li Z, Venkata JK, Long G, Mims A, Rizzieri D, Sarantopoulos S, Stuart R, Sung AD, Sullivan KM, Costa L, Horwitz M, Kang Y. Green MM, et al. Among authors: chao n. J Hematol Oncol. 2016 Aug 17;9(1):71. doi: 10.1186/s13045-016-0301-2. J Hematol Oncol. 2016. PMID: 27535663 Free PMC article. Clinical Trial.
Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.
Horwitz ME, Spasojevic I, Morris A, Telen M, Essell J, Gasparetto C, Sullivan K, Long G, Chute J, Chao N, Rizzieri D. Horwitz ME, et al. Among authors: chao n. Biol Blood Marrow Transplant. 2007 Dec;13(12):1422-6. doi: 10.1016/j.bbmt.2007.08.050. Biol Blood Marrow Transplant. 2007. PMID: 18022571 Free PMC article.
Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
McGaughey DS, Nikcevich DA, Long GD, Vredenburgh JJ, Rizzieri D, Smith CA, Broadwater G, Loftis JS, McDonald C, Morris AK, Folz RF, Chao NF. McGaughey DS, et al. Among authors: chao nf. Biol Blood Marrow Transplant. 2001;7(5):274-8. doi: 10.1053/bbmt.2001.v7.pm11400949. Biol Blood Marrow Transplant. 2001. PMID: 11400949 Free article. Clinical Trial.
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.
Craciunescu OI, Steffey BA, Kelsey CR, Larrier NA, Paarz-Largay CJ, Prosnitz RG, Chao N, Chute J, Gasparetto C, Horwitz M, Long G, Rizzieri D, Sullivan KM. Craciunescu OI, et al. Among authors: chao n. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1248-55. doi: 10.1016/j.ijrobp.2010.05.036. Epub 2010 Aug 26. Int J Radiat Oncol Biol Phys. 2011. PMID: 20800376 Free PMC article. Clinical Trial.
Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.
Tuchman SA, Bacon WA, Huang LW, Long G, Rizzieri D, Horwitz M, Chute JP, Sullivan K, Morris Engemann A, Yopp A, Li Z, Corbet K, Chao N, Gasparetto C. Tuchman SA, et al. Among authors: chao n. J Clin Apher. 2015 Jun;30(3):176-82. doi: 10.1002/jca.21360. Epub 2014 Oct 8. J Clin Apher. 2015. PMID: 25293363 Free PMC article.
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.
Huang LW, Bacon W, Cirrincione C, Peterson B, Long G, Rizzieri D, Sullivan KM, Corbet K, Horwitz M, Chao N, Gasparetto C, Tuchman SA. Huang LW, et al. Among authors: chao n. Hematol Oncol. 2017 Dec;35(4):752-759. doi: 10.1002/hon.2379. Epub 2017 Jan 19. Hematol Oncol. 2017. PMID: 28105753 Free PMC article.
Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
Bohannon L, Tang H, Page K, Ren Y, Jung SH, Artica A, Britt A, Islam P, Siamakpour-Reihani S, Giri V, Lew M, Kelly M, Choi T, Gasparetto C, Long G, Lopez R, Rizzieri D, Sarantopoulos S, Chao N, Horwitz M, Sung A. Bohannon L, et al. Among authors: chao n. Transplant Cell Ther. 2021 Aug;27(8):669.e1-669.e8. doi: 10.1016/j.jtct.2021.05.002. Epub 2021 May 12. Transplant Cell Ther. 2021. PMID: 33991725 Free PMC article.
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.
Pabon CM, Li Z, Hennig T, de Castro C, Neff JL, Horwitz ME, LeBlanc TW, Long GD, Lopez RD, Sung AD, Chao N, Gasparetto C, Sarantopoulos S, Adams DB, Erba H, Rizzieri DA. Pabon CM, et al. Among authors: chao n. Blood Cancer J. 2021 May 16;11(5):92. doi: 10.1038/s41408-021-00481-9. Blood Cancer J. 2021. PMID: 33994546 Free PMC article. No abstract available.
512 results